Article Information
History
- July 20, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Prachi A. Patkee1,
- Ana A. Baburamani1,
- Katherine R. Long2,3,
- Ralica Dimitrova1,4,
- Judit Ciarrusta1,4,
- Joanna Allsop1,
- Emer Hughes1,
- Johanna Kangas4,
- Grainne McAlonan4 and
- Mary A. Rutherford1,*
- 1Centre for the Developing Brain, School of Biomedical Engineering and Imaging Sciences, King’s College London, St. Thomas’ Hospital, London, SE1 7EH, UK
- 2Centre for Developmental Neurobiology, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, SE1 1UL, UK
- 3MRC Centre for Neurodevelopmental Disorders, King’s College London, SE1 1UL, UK
- 4Department of Forensic and Neurodevelopmental Science, Sackler Institute for Translational Neurodevelopment, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, SE5 8AB, UK
- ↵*Corresponding author email: prachi.patkee{at}kcl.ac.uk
Posted July 20, 2020.
Neurometabolite Mapping Highlights Elevated Myo-inositol Profiles within the Developing Brain in Down Syndrome
